Does bridging radiation therapy affect the pattern of failure after CAR T-cell therapy in non-Hodgkin lymphoma?-Reference-Cited by-同舟云学术

Does bridging radiation therapy affect the pattern of failure after CAR T-cell therapy in non-Hodgkin lymphoma?

Published:2022-01 Issue: Volume:166 Page:171-179
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Saifi Omran,Breen William G.,Lester Scott C.,Rule William G.,Stish Bradley,Rosenthal Allison,Munoz Javier,Herchko Steven M.,Murthy Hemant S.,Lin Yi,Bansal Radhika,Hathcock Matthew A.,Bennani N. Nora,Paludo Jonas,Wang Yucai,Khurana Arushi,Bisneto Jose C. Villasboas,Johnston Patrick B.,Ansell Stephen M.,Iqbal Madiha,Tun Han,Ayala Ernesto,Kharfan-Dabaja Mohamed A.,Hoppe Bradford S.,Peterson Jennifer L.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference33 articles.

1. CD19 antigen in leukemia and lymphoma diagnosis and immunotherapy;Scheuermann;Leuk Lymphoma,1995

2. Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells;Gattinoni;J Exp Med,2005

3. Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial;Locke;Lancet Oncol,2019

4. Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma;Schuster;N Engl J Med,2019

5. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma;Neelapu;N Engl J Med,2017

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of patients with R/R B-cell NHL and limited (<5 sites) pre-CART disease bridged with or without radiotherapy;Blood Advances;2024-09-24

2. Case report: Bridging radiation therapy before chimeric antigen receptor T-cell therapy induces sustained remission in patients with relapsed/refractory double-expressor diffuse large B-cell lymphoma with localized compressive symptoms;Frontiers in Immunology;2024-09-03

3. Management of bone disease with concurrent chimeric antigen receptor T-cell therapy for multiple myeloma;Critical Reviews in Oncology/Hematology;2024-09

4. Radiation Therapy Dose Response in Bulky Relapsed/Refractory Large B-Cell Lymphoma;Practical Radiation Oncology;2024-09

5. Comprehensive Bridging Radiotherapy for Limited Pre-CART Non-Hodgkin Lymphoma;JAMA Oncology;2024-07-01